Analysis of Opioid Prescribing Trends Following Thyroidectomy and Parathyroidectomy Before and After the 2021 American Academy of Otolaryngology–Head and Neck Surgery Opioid Prescribing Clinical Practice Guidelines
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.1008 ↗Kurz gefasst
Leitlinie in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Robert E Africa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Thyroidectomy, Parathyroidectomy, Analgesics, Opioid, Postoperative Pain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the trends in opioid and nonopioid prescribing for thyroidectomy and parathyroidectomy before and after the publication of guidelines by the American Academy of Otolaryngology–Head and Neck Surgery in April 2021. Study Design Retrospective.
Setting
Eighty‐three health care organizations in the United States that contribute to the TriNetX database.
Methods
Deidentified patient data were retrieved from the TriNetX. Patients who were prescribed either opioids or nonopioid analgesic within 1 to 5 days following thyroid surgery and parathyroidectomy were included. Evaluation of the prescription trends was performed by interrupted time series analysis in Statistical Analysis System 9.4 with significance set at P < .05 to assess trends before and after the new opioid prescription guidelines.
Results
For thyroid surgery, there was an immediate effect of the guideline change indicated by a 3.3% decrease in the opioid prescription trend ( P = .03) and a significant increase in nonopioid use of overtime by 0.13% every 3 months ( P < .0001). The opioid prescription trend following parathyroidectomy significantly decreased over time by 0.28% every 3 months ( P < .0001), while the nonopioid prescription trend increased by 0.14% ( P < .0001).
Conclusion
There was an associated immediate reduction in the opioid prescribing trend for thyroidectomy, but the change was not sustained overtime. There was an associated decrease in the opioid prescribing trend for parathyroidectomy, but not immediately after the initial publication of the prescription guidelines. Level of Evidence Level III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Texas Medical Branch, Galveston, Texas, USA.
ORCID-Profile: Robert E Africa
Zitieren
APA
Africa, R. E., McKinnon, B. J., Coblens, O. M., Ranasinghe, V. J., & Shabani, S. (2024). Analysis of Opioid Prescribing Trends Following Thyroidectomy and Parathyroidectomy Before and After the 2021 American Academy of Otolaryngology–Head and Neck Surgery Opioid Prescribing Clinical Practice Guidelines. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1008
Vancouver
Africa RE, McKinnon BJ, Coblens OM, Ranasinghe VJ, Shabani S. Analysis of Opioid Prescribing Trends Following Thyroidectomy and Parathyroidectomy Before and After the 2021 American Academy of Otolaryngology–Head and Neck Surgery Opioid Prescribing Clinical Practice Guidelines. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.1008
BibTeX
@article{Africa2024,
author = {Africa, Robert E and McKinnon, Brian J and Coblens, Orly M and Ranasinghe, Viran J and Shabani, Sepehr},
title = {Analysis of Opioid Prescribing Trends Following Thyroidectomy and Parathyroidectomy Before and After the 2021 American Academy of Otolaryngology–Head and Neck Surgery Opioid Prescribing Clinical Practice Guidelines},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.1008}
}
EUVIMED